Agencies grant 1-year extension of telemedicine prescribing flexibilities
The Drug Enforcement Administration and Department of Health and Human Services Nov. 15 issued a final rule extending certain telemedicine prescribing flexibilities for an additional year. As urged by the AHA, the agencies will waive the in-person visit requirement prior to the prescribing of controlled substances virtually until Dec. 31, 2025. The flexibilities were granted during the COVID-19 public health emergency and were set to expire at the end of this year.
Related News Articles
Headline
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump…
Headline
A bipartisan group of 60 senators April 2 reintroduced the CONNECT for Health Act, AHA-supported legislation that would expand patient access to telehealth…
Headline
Today the Drug Enforcement Administration and Department of Health and Human Services announced that the effective date for the final rule regarding…
Headline
The Department of Health and Human Services and Drug Enforcement Administration published a series of rules Jan. 15 related to telemedicine prescribing of…
Headline
The Department of Health and Human Services Health Sector Cybersecurity Coordination Center Jan. 8 released guidance on cybersecurity for telehealth…
Headline
In comments Nov. 12 to majority and minority leaders of the House and Senate, the AHA requested that Congress act on key priorities for hospitals and health…